Prevention of oxidative stress-mediated neuropathology and improved clinical outcome by adjunctive use of a combination of antioxidants and omega-3 fatty acids in schizophrenia.
about
Proteome analysis of schizophrenia patients Wernicke's area reveals an energy metabolism dysregulationOxidative stress in schizophreniaAntioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view.Reduced antioxidant defense in early onset first-episode psychosis: a case-control study.Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients.Effects of dietary fish oil on the depletion of carcinogenic PAH-DNA adduct levels in the liver of B6C3F1 mouse.Seafood types and age-related cognitive decline in the Women's Health Study.Neuroprotection of paliperidone on SH-SY5Y cells against β-amyloid peptide(25-35), N-methyl-4-phenylpyridinium ion, and hydrogen peroxide-induced cell death.Clozapine protects PC-12 cells from death due to oxidative stress induced by hydrogen peroxide via a cell-type specific mechanism involving inhibition of extracellular signal-regulated kinase phosphorylation.First-episode psychosis is associated with oxidative stress: Effects of short-term antipsychotic treatment.Beneficial effects of N-acetylcysteine in treatment resistant schizophrenia.Oxidative stress-mediated essential polyunsaturated fatty acid alterations in female infertility.Neuroprotective efficacy of a combination of fish oil and ferulic acid against 3-nitropropionic acid-induced oxidative stress and neurotoxicity in rats: behavioural and biochemical evidence.Dietary glucoraphanin prevents the onset of psychosis in the adult offspring after maternal immune activation.Oxidative status and the severity of clinical symptoms in patients with post-traumatic stress disorder.Fatty acids, antioxidants, and oxidative stress in pre-eclampsia.
P2860
Q21260256-5A34BDFE-1481-498D-9E9B-1BABD9F8D6F8Q24595660-C4CE8595-99AC-4A1C-B0F5-DA48FBC8C966Q33350202-DB34733F-70AA-499E-B26A-8B2994AA8409Q33820188-41C9759A-1536-4DC6-AA44-3F8BF5DC3997Q33979025-3FA26F12-E7A3-4274-9294-545B4E445088Q34069595-98682894-3E44-4F6B-AA38-4ABEADE4B5C7Q37189195-B1F2B723-3514-474F-BF71-062839C2526AQ39552320-CAF0E067-33A6-4363-80BD-B06C9A86FEA8Q39842108-DE1648D1-82A4-4320-B34D-E8BA64D0A3B3Q42479721-FD70A164-64D0-4DD4-883B-4ACC55FF1769Q43280102-232112FD-5C3E-4432-8AD3-5BE538CE0872Q46069772-B4EAF369-330F-469C-8C38-3021BFCC8663Q46914176-65641252-57B4-4627-AACA-7EF520E5FB77Q47549654-63256909-5C1E-4EA0-A7B0-3D76E93748A6Q47892656-4E67D4D2-CF75-417D-B124-91A09EE38F08Q50671558-D9808A37-467D-4EC0-9E7A-9F77774BB5A5
P2860
Prevention of oxidative stress-mediated neuropathology and improved clinical outcome by adjunctive use of a combination of antioxidants and omega-3 fatty acids in schizophrenia.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Prevention of oxidative stress ...... fatty acids in schizophrenia.
@ast
Prevention of oxidative stress ...... fatty acids in schizophrenia.
@en
type
label
Prevention of oxidative stress ...... fatty acids in schizophrenia.
@ast
Prevention of oxidative stress ...... fatty acids in schizophrenia.
@en
prefLabel
Prevention of oxidative stress ...... fatty acids in schizophrenia.
@ast
Prevention of oxidative stress ...... fatty acids in schizophrenia.
@en
P2093
P2860
P1476
Prevention of oxidative stress ...... fatty acids in schizophrenia.
@en
P2093
Adriana Foster
Anilkumar Pillai
Sadhana Joshi
Sahebarao P Mahadik
P2860
P304
P356
10.1080/09540260600581993
P577
2006-04-01T00:00:00Z